Bending the curve on psychosis outcomes.

about

Mismatch Negativity is a Sensitive and Predictive Biomarker of Perceptual Learning During Auditory Cognitive Training in Schizophrenia.Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia.

P2860

Q38763964-BA0F418A-EF69-4E9E-9CEA-A3B5ABC1D050 Q38829187-B5B65252-A0E6-466E-B055-53D231CE19F5

P2860

Bending the curve on psychosis outcomes.

Item

http://www.wikidata.org/entity/Q41517439

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Bending the curve on psychosis outcomes.

@en

type

Item

label

Bending the curve on psychosis outcomes.

@en

prefLabel

Bending the curve on psychosis outcomes.

@en

P1476

Bending the curve on psychosis outcomes.

@en

P2093

Gregory A Light

http://www.w3.org/2001/XMLSchema#string

Neal R Swerdlow

http://www.w3.org/2001/XMLSchema#string

P2860

Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia

Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia

Neurophysiological models for new treatment development in schizophrenia: early sensory approaches.

Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.

Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia.

The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study.

Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study

Mismatch negativity as a "translatable" brain marker toward early intervention for psychosis: a review.

The psychosis high-risk state: a comprehensive state-of-the-art review.

D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial.

P304

365-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S2215-0366(15)00172-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26360262

http://www.w3.org/2001/XMLSchema#string

P921

psychosis

P932

5072396

http://www.w3.org/2001/XMLSchema#string

Bending the curve on psychosis outcomes.

about

P2860

P2860

Bending the curve on psychosis outcomes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932